Skip to content
healthcare.dev

Methocarbamol Tablets, USP, 750 mg

NDC 10135-723, Methocarbamol, tablet, film coated, from Marlex Pharmaceuticals, Inc..

Product NDC
10135-723
Status
Listed
Labeler
Marlex Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212623
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10135-723 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOCARBAMOL750 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
10135-723-0110135072301100 TABLET, FILM COATED in 1 BOTTLE (10135-723-01)
10135-723-0510135072305500 TABLET, FILM COATED in 1 BOTTLE (10135-723-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2e38ac9-1cf3-14ca-e053-2a95a90a8522

Use it

Look up 10135-723 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10135-723 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10135-723. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.